Most Recent
Funder spars with judge as Westpac’s common fund challenge looms
The litigation funder at the centre of a challenge by Westpac to the Federal Court's power to make common fund orders faced a fiery judge in a tense exchange Friday, after it revealed it was weighing a bid to pause a class action against the bank until after the appeal.
Qantas slammed for ‘ridiculous’ particulars request in Fair Work case
A Federal Court judge on Friday called a request for particulars by Qantas "ridiculous", during the first hearing in a case brought by mechanics alleging they weren't pay allowances owed while working on assignment in Los Angeles.
Apotex settles patent suit over generic Lexapro
Generic drug company Apotex has settled a patent infringement case brought by global pharmaceutical giant Lundbeck over its blockbuster antidepressant Lexapro.
ASIC defeats referee bid in AMP insurance case
ASIC has successfully opposed a Federal Court judge's push to appoint an independent referee in its case against AMP Financial Planning over alleged insurance churning.
ACCC’s loss in Pfizer misuse of market power case to stand
The High Court has dismissed the ACCC's bid to appeal a Full Federal Court decision upholding a ruling that drug giant Pfizer did not misuse its market power in the months leading up to the expiration of the patent for its blockbuster cholesterol drug Lipitor.
PwC gets court ok to file lawsuit against Vocation
PriceWaterHouse Coopers has received the green light to launch court action to pursue its cross claims against failed educational training company Vocation.
High Court won’t hear Yazaki appeal of $46M fine
Japanese car parts manufacturer Yazaki will have to pay a $46 million penalty for price-fixing, now that the High Court has refused to hear its appeal of the record competition fine.
ACCC sets new bar for competition penalties
The ACCC secured $120.1 million in competition penalties in the 2017-18 financial year, including a record $46 million fine, and with a strong influx of immunity applications throughout the year, the cartel cop shows no signs of slowing down.
AFT Pharma’s Maxigesic ads misleading, judge rules
AFT Pharmaceuticals breached the consumer laws with misleading ads over the strength of its painkiller Maxigesic, a judge has found, siding with rival drug maker Reckitt Benckiser.
Wyeth resolves Commonwealth’s claims over generic Effexor delay
The Commonwealth of Australia has resolved its claims against pharmaceutical giant Wyeth over the price it paid to list Effexor on the PBS, months after a high stakes trial wrapped up.